[Digitalization in cytostatic therapy].
D000113:Acetyldigoxins / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001761:Bleomycin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004071:Digitalis Glycosides / Q000494:pharmacology / Q000627:therapeutic use*; D004074:Digitoxin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000494:pharmacology; D011344:Procarbazine / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000113:Acetyldigoxins; D000970:Antineoplastic Agents; D004071:Digitalis Glycosides; D003561:Cytarabine; D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D004074:Digitoxin; D011241:Prednisone
Digitalisierung bei zytostatischer Therapie.